Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
City of Hope Medical Center
Ohio State University Comprehensive Cancer Center
University of Chicago
Case Comprehensive Cancer Center
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
European Organisation for Research and Treatment of Cancer - EORTC
Groupe Oncologie Radiotherapie Tete et Cou
Duke University